Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-3088-2026

Medos International Sarl recalls Velys Enabling Tech Robotic-Assist Station REF: 451611001

Medos International SarlLe Locle, SwitzerlandReported Sep 9, 2026 · 6 days ago
Legal News Analyst ·

Reason for recall

Software issue within robotic controller which may cause unintended movement of the robotic arm during bone preparation or instrument positioning.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • Velys Enabling Tech Robotic-Assist Station REF:451611001
    UDI 10705034645995/Serial
    29 affected lots
    W14316295301W15316297501W15316298001W17316322901W17316323301W21316347401W21316347501W21316347601
    +21 moreW21316347801W21316347901W21316348001W22316365801W34316479001W34316479101W34316479201W34316479301W34316479401W34316479601W34316479801W34316480001W34316480101W49316554301W51316597001W51316597101Y03316603601Y03316603701Y03316603801Y07316625901Y15316690901

What the firm is doing

On July 23, 2026, DePuy Synthes contacted affected consigenees via phone call concerning the recall. On July 24, 2026 Depuy issued a Urgent Medical Device Correction notification via sales associate visit. DePuy ask consignees to take the following actions: 1. Do not use the subject VELYS ROBOTIC-ASSIST STATION and quarantine it immediately. The VELYS. 2. Navigation Station and VELYS Camera Station can continue to be used following the Instructions for Use. 3. Complete, sign, and return the attached Business Response Form to OneMD-Field-Actions@its.jnj.com within three (3) business days of receipt of this notification. 4. Forward this notice to anyone in your facility that needs to be informed 5. Post a copy of this notice in a visible area for awareness and keep a copy for your records. 6. As with any medical device, adverse reactions or quality problems experienced with the use of this product should be reported to the FDA's MedWatch Adverse Event Reporting Program Online: https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program/reportingserious

DistributionShow details

US Nationwide distribution in the states of DE, FL, IL, KY, MD, MI, MN, NJ, NM, NY, OR, PA, TN, TX, VA, WA.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls